This inventor holds 1 USPTO granted patent. Top assignee: Kemia, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Journey of Lubomir Sebo
Introduction
Lubomir Sebo, an accomplished inventor based in San Diego, CA, has made significant strides in the field of pharmaceutical innovations. With a focus on novel compounds, his contributions aim to provide therapeutic solutions for various medical conditions.
Latest Patents
Sebo holds a patent for "Modulators of Calcitonin and Amylin Receptor Activity." This innovative patent relates to the development of non-peptidic compounds that modulate the activity of calcitonin and amylin receptors. The compounds outlined in this patent hold potential as calcitonin and/or amylin agonists, offering new avenues for the treatment of bone diseases and metabolic disorders.
Career Highlights
Lubomir is associated with Kemia, Inc., where he engages in groundbreaking research and development. His dedication to advancing medical science through innovative solutions showcases his commitment to improving patient outcomes.
Collaborations
Throughout his career, Sebo has collaborated with talented individuals such as Kent Pryor and Jan Urban. These partnerships have enriched his work, fostering an environment of creative problem-solving and innovation in the pharmaceutical sector.
Conclusion
In summary, Lubomir Sebo's contributions to the field of pharmaceuticals not only reveal his inventive spirit but also highlight his role in shaping the future of healthcare. His patent on calcitonin and amylin receptor activity underscores the importance of innovation in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile